Skip to main content

Side Menu Card

Research Studies

Leukemia and Lymphoma Program Research Studies

Find research studies available to children cared for by the Leukemia and Lymphoma Program team.

Existing patients or family members
New patients, referrals and second opinions

Recruitment Status

Study categories

Specialty

Eligible age

SAR443579 in AML, B-ALL, or MDS

This study involves taking a study drug called SAR443579. The overall goal of this study is to find out if the study drug is safe and effective at treating adults and children with relapsed or refractory acute myeloid leukemia (R/R AML), high risk myelodysplastic syndrome (HR-MDS), or B-cell acute lymphoblastic leukemia (B-ALL). This is a first-in-human research study.

Phase: Phase I, Phase II

Actively recruiting: Yes

Category: Adults, Children

Conditions: Acute Myelogenous Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Pediatric Leukemias, Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)

Jump back to top